In vivo treatment of HCV core-positive HepG2 cells with the transfer of recombinant caspase-3 using a 2'-5' OAS promoter

Author：          

Publisher： Spandidos Publications

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.5, Iss.3, 2012-01, pp. : 631-636

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sasanquasaponin from Camellia oleifera Abel. induces apoptosis via Bcl-2, Bax and caspase-3 activation in HepG2 cells

By                

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-01 ,pp. : 1997-2002

Spandidos Publications

Access to resources Recommend Favorite

Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 7, 2017-06 ,pp. : 941-947

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of expression of hepatitis C virus 1b genotype core and NS4B genes in HepG2 cells using artificial microRNAs

By            

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-01 ,pp. : 1905-1913

Spandidos Publications

Access to resources Recommend Favorite

Overexpression of CYP3A5 attenuates inducibility and activity of CYP3A4 in HepG2 cells

By            

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2868-2874

Spandidos Publications

Access to resources Recommend Favorite

Identification of genes in HepG2 cells that respond to DNA methylation and histone deacetylation inhibitor treatment

By        

Experimental and Therapeutic Medicine, Vol. 8, Iss. 3, 2014-01 ,pp. : 813-817

Spandidos Publications

Access to resources Recommend Favorite